177 related articles for article (PubMed ID: 12227898)
21. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
22. The regulation of fibroid growth: time for a re-think?
Smith SK
Br J Obstet Gynaecol; 1993 Nov; 100(11):977-9. PubMed ID: 8251467
[No Abstract] [Full Text] [Related]
23. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma.
Ohara N
Clin Exp Obstet Gynecol; 2005; 32(1):9-11. PubMed ID: 15864926
[TBL] [Abstract][Full Text] [Related]
24. [Adjuvant therapy in uterine myoma].
Vikhliaeva EM
Vestn Ross Akad Med Nauk; 1997; (2):16-20. PubMed ID: 9376721
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effect of danazol therapy in women with uterine leiomyomata.
La Marca A; Musacchio MC; Morgante G; Petraglia F; De Leo V
Fertil Steril; 2003 May; 79(5):1240-2. PubMed ID: 12738528
[No Abstract] [Full Text] [Related]
26. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
Wang H; Jin J
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
[TBL] [Abstract][Full Text] [Related]
27. Growth factors and cytokines in uterine leiomyomas.
Andersen J
Semin Reprod Endocrinol; 1996 Aug; 14(3):269-82. PubMed ID: 8885057
[TBL] [Abstract][Full Text] [Related]
28. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
29. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
30. Medical treatment of symptomatic endometriosis.
Cirkel U
Hum Reprod; 1996 Nov; 11 Suppl 3():89-101. PubMed ID: 9147104
[TBL] [Abstract][Full Text] [Related]
31. Short-term treatment of uterine fibromyomas with danazol.
De Leo V; la Marca A; Morgante G
Gynecol Obstet Invest; 1999; 47(4):258-62. PubMed ID: 10352389
[TBL] [Abstract][Full Text] [Related]
32. [Pathogenesis and conservative therapy of uterine leiomyoma].
Mori T; Fujii S; Konishi I
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1144-9. PubMed ID: 3091738
[No Abstract] [Full Text] [Related]
33. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Friedman AJ; Lobel SM; Rein MS; Barbieri RL
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
[TBL] [Abstract][Full Text] [Related]
34. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
[TBL] [Abstract][Full Text] [Related]
35. Suppression of F-18 fluorodeoxyglucose uptake in benign uterine leiomyomas with danazol.
Tripathi M; Srivastava M; Garg G; Jaimini A; Singh N; Souza MD; Kaur P; Sharma R; Mandal A
Clin Nucl Med; 2009 Jul; 34(7):452-5. PubMed ID: 19542955
[No Abstract] [Full Text] [Related]
36. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial.
Fiscella K; Eisinger S
Obstet Gynecol; 2008 Sep; 112(3):707; author reply 707-8. PubMed ID: 18757682
[No Abstract] [Full Text] [Related]
37. Medical treatment of uterine fibroids.
Chavez NF; Stewart EA
Clin Obstet Gynecol; 2001 Jun; 44(2):372-84. PubMed ID: 11347559
[No Abstract] [Full Text] [Related]
38. Endocrine therapy in metastatic breast cancer.
Kimmick GG; Muss HB
Cancer Treat Res; 1998; 94():231-54. PubMed ID: 9587691
[TBL] [Abstract][Full Text] [Related]
39. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
40. [Estrogens and leiomyoma of the uterus].
Murakami T
Nihon Rinsho; 2006 Apr; 64 Suppl 4():364-9. PubMed ID: 16689335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
